Intrinsic Value of S&P & Nasdaq Contact Us

Phreesia, Inc. PHR NYSE

NYSE • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
58/100
3/7 Pass
SharesGrow Intrinsic Value
$544.71
+6233.8%
Analyst Price Target
$27.50
+219.8%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Phreesia, Inc. (PHR) trades at a trailing P/E of 216.8, forward P/E of 26.7. Trailing earnings yield is 0.46%, forward earnings yield 3.75%. PEG 0.04 (Peter Lynch undervalued ≤1.0). Graham Number is $2.21.

Criteria proven by this page:

  • VALUE (50/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
  • Forward P/E 26.7 (down from trailing 216.8) — analysts expect earnings to grow, which would improve the valuation.
  • PEG Ratio 0.04 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield 0.46% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 3.75% as earnings recover.
  • Analyst consensus target $27.50 (+219.8% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 58/100 with 3/7 criteria passed.

SharesGrow 7-Criteria Score
58/100
SG Score
View full scorecard →
~
VALUE
50/100
Price-to-Earnings & upside
Proven by this page
FUTURE
94/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
64/100
→ Income
GROWTH
90/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — PHR

Valuation Multiples
P/E (TTM)216.8
Forward P/E26.7
PEG Ratio0.04
Forward PEG0.04
P/B Ratio1.48
P/S Ratio1.06
EV/EBITDA18.2
Per Share Data
EPS (TTM)$0.04
Forward EPS (Est.)$0.32
Book Value / Share$5.64
Revenue / Share$8.04
FCF / Share$1.07
Yields & Fair Value
Earnings Yield0.46%
Forward Earnings Yield3.75%
Dividend Yield0.00%
Graham Number$2.21
SharesGrow IV$544.71 (+6233.8%)
Analyst Target$27.50 (+219.8%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2018 -2.1 0.00 -0.23 0.48 -
2019 -3.1 0.10 -0.22 0.46 -
2020 -31.0 0.35 6.18 5.04 2.38%
2021 -96.6 3.12 10.02 17.74 -
2022 -13.2 -0.05 3.73 7.30 -
2023 -11.2 -0.27 6.83 7.00 -
2024 -10.2 0.40 5.53 3.90 -
2025 -28.0 0.47 6.19 3.90 -
2026 -39.7 0.38 2.38 1.67 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2018 $-11.82 $79.83M $-18.19M -22.8%
2019 $-8.16 $99.89M $-15.06M -15.1%
2020 $-1.00 $124.78M $-20.29M -16.3%
2021 $-0.69 $148.68M $-27.29M -18.4%
2022 $-2.37 $213.23M $-118.16M -55.4%
2023 $-3.36 $280.91M $-176.15M -62.7%
2024 $-2.51 $356.3M $-136.89M -38.4%
2025 $-1.02 $419.81M $-58.53M -13.9%
2026 $0.04 $480.59M $-20.19M -4.2%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $0.08 $0.03 – $0.18 $480.14M $479.27M – $481.32M 9
2027 $0.52 $0.25 – $0.96 $552.09M $549.28M – $554.89M 8
2028 $0.78 $0.45 – $1.35 $601.04M $565.78M – $633.33M 7
2029 $0.93 $0.69 – $1.11 $654.33M $628.67M – $682.2M 4
2030 $1.16 $1.12 – $1.23 $717.1M $688.97M – $747.64M 2
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message